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Is DEET safe for children?
■ Evidence summary
The increasing prevalence of mosquito-
borne diseases, including West Nile virus,
has raised concerns about safe and effec-
tive forms of prevention. For decades, par-
ents have used the insect repellent DEET
(N,N-diethyl-metatoluamide), but ques-
tions remain regarding adverse effects,
including seizures, particularly when used
in children.
Two large case series suggested that
the risk of DEET is low. The first collected
poison control center reports during the
1980s. The report concluded that DEET
exposure rarely led to adverse effects and
that the route of administration (ie, inges-
tion) was more closely linked to toxicity
than age or gender.1 There were 5 major
adverse reactions reported from 9086
exposures to DEET (0.05%); these includ-
ed hypotension, hypotonic reaction, and
syncope, and 1 death (a suicide ingestion).  
The second series, also collected from
poison control centers, included roughly
21,000 reports of DEET exposures during
the 1990s. The authors concluded that the
risk of toxicity was low and that there was
no clear dose-dependent relationship
between exposure and extent of severity of
neurologic manifestations.2 This report
found a rate of major adverse reactions
(0.1%) from DEET that was similar to the
first case series. The major reactions
reported included hypotension, seizures,
respiratory distress, and 2 deaths (0.01%).
When limiting the data to infants and chil-
dren only, there were 10 major events
among 17,252 reported exposures
(0.06%), and no deaths. Although infants
and children accounted for 83.1% of all
reported exposures, the majority of the
serious outcomes (including the deaths)
occurred in adults. About half of all those
exposed reportedly had no ill effects, the
Counsel parents to take 3 steps to prevent bites—
avoid, cover up, and repel
The emergence of West Nile virus has heightened awareness
of mosquitoes, and I often field questions about how to 
protect children from bites. I counsel parents to take 3 steps
to prevent bites—avoid, cover up, and repel. Mosquitoes are
active at dawn and dusk, so staying indoors during these
times is protective. Covering up with long sleeves, pants, and
socks protects from most bites. Lastly, DEET repellent 
protects exposed areas from mosquitoes. Lotions make it
easier to apply DEET to children. Commonly, parents express
fear of DEET due to media reports. This review will help me
ease their fears.
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Reported evidence suggests that DEET use is safe for children
older than 2 months, with only very rare incidence of major
adverse effects (strength of recommendation [SOR]: C).
Typically, a topical concentration between 10% and 30%
should be used (SOR: C). Increasing DEET concentration does
not improve protection, but does increase the duration of
action (SOR: A).
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other half had minor effects (transient
effects that resolved without treatment).
Only 4% experienced moderate effects
(non–life threatening problem, but one
that would likely require treatment). There
were no data presented on the overall size
of the exposed population, eg, users of
DEET in the US.
Two recent narrative reviews also 
concluded that DEET toxicity is rare in
children. The first review found that DEET
posed essentially no risk in children.3 The
second review was sponsored by SC
Johnson and Company, the makers of
OFF! brand insect repellent. It assessed
animal studies, epidemiologic data, and
case reports, and supported the safety of
DEET in children.4
A theoretical risk is that DEET toxici-
ty could be enhanced by coapplication
with other agents. Some studies have
uncovered dangerous interactions with
military and industrial chemicals, but such
exposures are unlikely in most children.
The most practical concern regards sun-
screen. One study reported that use of sun-
screen increased the penetration of DEET.5
However, since the poison control center
studies indicated that toxicity did not
occur in a dose-dependent manner; the
clinical significance of increased penetra-
tion is not clear.1,2
Increasing the concentration of DEET
does not improve protection but does pro-
vide longer duration. Concentrations of
6.65% protect for about 2 hours while
23.8% DEET can last about 5 hours.6 By
understanding this relationship, parents
can apply lowest concentration necessary
to provide the protection needed.
Recommendations from others
The American Academy of Pediatrics 
recommends avoiding DEET in children
under 2 months of age. For all other 
children, it advises using DEET with a con-
centration between 10% and 30%.7
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DEET at 10%–30%
concentration 
is safe for children
older than 2
months; increased
concentration 
prolongs action
but does not
improve protection
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What are 
Clinical Inquiries?
Clinical Inquiries answer recent questions from 
the practices of family physicians.  Practicing family
physicians choose the most relevant questions submit-
ted through a web-based voting system operated by
the Family Physicians Inquiries Network (FPIN; online
at www.fpin.org). 
FPIN is national, not-for-profit consortium of family
medicine departments, community residency pro-
grams, academic health sciences libraries, primary
care practice-based research networks, and other 
specialists.  Once questions are selected, FPIN editors
then organize teams of clinicians and librarians to
answer them based on systematic review of the world
literature. Answers are developed through an explicit,
systematic method:
❚ FPIN librarians and editors identify questions recent-
ly answered in best evidence sources (e.g. Cochrane
Reviews, Clinical Evidence, the US Preventive
Services Task Force, Evidence Based Guidelines, a
published systematic review).
❚ FPIN librarians then conduct systematic and 
standardized literature searches of best evidence
sources, Medline, and other databases in collabora-
tion with an FPIN clinician or clinicians. If a best 
evidence source has been identified, the search
begins from the date of the search conducted for that
source. Otherwise, the searches are comprehensive. 
❚ FPIN clinician authors then choose the highest 
quality original research sources, and critically
appraise the research and integrate the findings in
the Evidence Based Answer and Evidence Summary 
section of Clinical Inquiries. Authoritative sources are
also quoted in the “Recommendations from Others”
section of the Clinical Inquiry.
❚ Each Clinical Inquiry is reviewed by 4 or more peers
or editors before publication in JFP.
❚ FPIN medical librarians are accountable for the 
thoroughness of the literature search, for recording
the databases searched, search hedges used and
the search terms.  The details of each search is
available to any interested reader 
(contact managingeditor@fpin.org).
❚ Finally, a practicing family physician or other 
clinician writes an accompanying commentary to
provide a clinical perspective.
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